S Barreau

This is an unedited manuscript that has been accepted for publication. NPG are providing this early version of the manuscript as a service to our customers. The manuscript will undergo copyediting, typesetting and a proof review before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers apply.

On the basis of these results, we investigated whether mTORC1 signaling could drive a metabolic reprogramming of AML cells which could be targeted for therapy. Our data indicate that mTORC1 specifically promotes glycolysis and glucose addiction in AML cells. Furthermore, we observed that AML cells rely on glucose metabolism for their survival mainly for sustaining a high flux of glucose through the PPP.